SARS-CoV-2 Nucleocapsid Antibody (6A8) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-05729
Key Product Details
Species Reactivity
SARS-CoV-2
Applications
ELISA, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2B Clone # 6A8
Format
Azide and BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
Recombinant SARS-CoV-2 N protein (His-tag)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Scientific Data Images for SARS-CoV-2 Nucleocapsid Antibody (6A8) - Azide and BSA Free
Western Blot: SARS-CoV-2 Nucleocapsid Antibody (6A8)Azide and BSA Free [NBP3-05729]
Western Blot: SARS-CoV-2 Nucleocapsid Antibody (6A8) [NBP3-05729] - Validation of SARS-CoV-2 Nucleocapsid AntibodyLane 1: 50ng, Lane 2: 25ng, Lane 3: 5ng, Lane 4: 2ng , Lane 5: 1ng and Lane 6: 0.5ng of SARS-CoV-2 N protein probed with SARS-CoV-2 Nucleocapsid Antibody [6A8], at 1:1000 dilution and 4C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37C.Applications for SARS-CoV-2 Nucleocapsid Antibody (6A8) - Azide and BSA Free
Application
Recommended Usage
ELISA
1:5000-1000
Western Blot
1:500-2000
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
0.01M PBS, pH7.4
Format
Azide and BSA Free
Preservative
0.1% Proclin 300
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SARS-CoV-2 Nucleocapsid
Following SARS-CoV-2 infection, B cells and T cells display an immune response against nucleocapsid protein and nucleocapsid-specific neutralizing antibodies are produced (5). Interestingly, a study of patients who have recovered from COVID-19 revealed that there were no neutralizing antibodies against nucleocapsid protein present; however, a high presence against neutralizing spike RBD antibodies were detected (5).
References
1. Pillay T. S. (2020). Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein. Journal of Clinical Pathology. https://doi.org/10.1136/jclinpath-2020-206658
2. Malik Y. A. (2020). Properties of Coronavirus and SARS-CoV-2. The Malaysian Journal of Pathology.
3. Zhu, G., Zhu, C., Zhu, Y., & Sun, F. (2020). Minireview of progress in the structural study of SARS-CoV-2 proteins. Current Research in Microbial Sciences. https://doi.org/10.1016/j.crmicr.2020.06.003
4. Uniprot (P0DTC9)
5. Shah, V. K., Firmal, P., Alam, A., Ganguly, D., & Chattopadhyay, S. (2020). Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.01949
Alternate Names
2019-nCoV N Protein, 2019-nCoV Nucleocapsid Protein, COVID-19 N protein, COVID-19 nucleocapsid protein, Human coronavirus Nucleoprotein, nucleocapsid phosphoprotein, Nucleocapsid protein, Nucleoprotein, ORF9; structural protein, SARS-CoV-2, SARS-CoV-2 Nucleocapsid protein, SARS-CoV-2 N protein, SARSCoV2 Nucleoprotein, Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Protein
Gene Symbol
N
Additional SARS-CoV-2 Nucleocapsid Products
Product Documents for SARS-CoV-2 Nucleocapsid Antibody (6A8) - Azide and BSA Free
Product Specific Notices for SARS-CoV-2 Nucleocapsid Antibody (6A8) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...